Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
GAVISCON |
| Manufacturer |
|
GlaxoSmithKline Pharmaceuticals |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Antacid. |
| Generic Name |
|
Aluminum hydroxide 80mg, magnesium trisilicate 20mg; chew tabs. |
| Also |
• GAVISCON EXT STR LIQUID
• GAVISCON EXT STR TABS
• GAVISCON LIQUID
|
| Indications |
|
Heartburn, indigestion, reflux. |
| Children |
|
Not recommended. |
| Adults |
|
2–4 tabs, or 15–30mL of Reg Str liq, or 10–20mL of Ext Str liq, 4 times daily. |
| Precautions |
|
Renal dysfunction. Sodium restricted diet. |
| Interactions |
|
Reduces absorption of tetracyclines, others. |
| Adverse Reactions |
|
Diarrhea, constipation. |
| How Supplied |
Tabs—30, 100
Liq—6oz, 12oz
Ext Str tabs—30, 100
Ext Str liq—12oz |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
